Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations

Journal of the American Academy of Dermatology

Volumn 58, Issue 2 SUPPL. 1, 2008, Pages

  Eisendle, Klaus ^a   Linder, Dennis ^b   Ratzinger, Gudrun ^a   Zelger, Bernhard ^a   Philipp, Wolfgang ^a   Piza, Hildegunde ^a   Fritsch, Peter ^a   Schmuth, Matthias ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Civic Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ANTILIPEMIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; ETOPOSIDE; FIBRIC ACID DERIVATIVE; GAMMA INTERFERON; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; ROSIGLITAZONE; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; ELECTRON MICROSCOPY; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIPID ANALYSIS; LIPID STORAGE; MACROPHAGE; MALE; PRIORITY JOURNAL; XANTHOMA; XANTHOMA DISSEMINATUM;

ADULT; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; PYRAZINES; SIMVASTATIN; THIAZOLIDINEDIONES;

EID: 38049030676     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.032     Document Type: Article

References (5)

1. Zelger B., Cerio R., Orchard G., Fritsch P., and Wilson-Jones E. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Dermatol 128 (1992) 1207-1212
2. Caputo R., Veraldi S., Grimalt R., Gianotti R., Tosti A., Varotti C., et al. The various clinical patterns of xanthoma disseminatum: considerations on seven cases and review of the literature. Dermatology 190 (1995) 19-24
3. Knobler R.M., Neumann R.A., Gebhart W., Radaskiewicz T., Ferenci P., and Widhalm K. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems. J Am Acad Dermatol 23 (1990) 341-346
4. Seaton E.D., Pillai G.J., and Chu A.C. Treatment of xanthoma disseminatum with cyclophosphamide. Br J Dermatol 150 (2004) 346-349
5. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86